Total Payments
$14,573
2024 Payments
$2,447
Companies
29
Transactions
705
Medicare Patients
2,060
Medicare Billing
$298,321
Payment Breakdown by Category
Food & Beverage$14,546 (99.8%)
Education$26.82 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,546 | 702 | 99.8% |
| Education | $26.82 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,638 | 198 | $0 (2024) |
| PFIZER INC. | $1,924 | 111 | $0 (2024) |
| ABBVIE INC. | $1,626 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,205 | 49 | $0 (2024) |
| Lilly USA, LLC | $1,059 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $924.18 | 24 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $674.82 | 21 | $0 (2024) |
| Horizon Therapeutics plc | $572.15 | 61 | $0 (2023) |
| UCB, Inc. | $547.73 | 35 | $0 (2024) |
| Genentech USA, Inc. | $506.32 | 27 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,447 | 118 | ABBVIE INC. ($655.05) |
| 2023 | $2,805 | 121 | Amgen Inc. ($650.56) |
| 2022 | $2,036 | 106 | Amgen Inc. ($462.07) |
| 2021 | $542.37 | 33 | Amgen Inc. ($189.25) |
| 2020 | $1,060 | 48 | Amgen Inc. ($339.92) |
| 2019 | $2,552 | 97 | Amgen Inc. ($576.30) |
| 2018 | $1,931 | 106 | PFIZER INC. ($510.88) |
| 2017 | $1,199 | 76 | PFIZER INC. ($334.57) |
All Payment Transactions
705 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Immunology | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 436 | 916 | $121,451 | $74,081 |
| 2022 | 7 | 503 | 977 | $127,468 | $77,553 |
| 2021 | 6 | 496 | 947 | $120,010 | $73,142 |
| 2020 | 9 | 625 | 1,140 | $145,574 | $73,545 |
Total Patients
2,060
Total Services
3,980
Medicare Billing
$298,321
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 432 | $68,316 | $41,219 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 418 | $42,456 | $27,679 | 65.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $7,635 | $3,983 | 52.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 21 | $2,837 | $1,076 | 37.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 22 | $207.24 | $124.08 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 431 | $68,150 | $42,032 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 422 | $42,863 | $27,805 | 64.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $9,958 | $5,222 | 52.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 33 | $4,458 | $1,619 | 36.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $1,157 | $543.17 | 46.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 16 | $580.96 | $176.31 | 30.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 24 | 32 | $301.44 | $155.14 | 51.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 388 | $61,351 | $37,817 | 61.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 217 | 429 | $43,574 | $28,348 | 65.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $7,635 | $4,238 | 55.5% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 21 | 47 | $6,349 | $2,354 | 37.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 20 | $726.20 | $222.30 | 30.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 32 | 40 | $376.80 | $162.48 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 415 | $65,620 | $33,187 | 50.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 246 | 492 | $49,972 | $26,992 | 54.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 36 | 36 | $11,950 | $6,129 | 51.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $6,069 | $3,090 | 50.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 28 | 53 | $7,159 | $2,575 | 36.0% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2020 | 12 | 20 | $2,010 | $544.57 | 27.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 13 | $1,157 | $475.96 | 41.1% |
About Dr. Alan Oki, MD
Dr. Alan Oki, MD is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982657268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Oki, MD has received a total of $14,573 in payments from pharmaceutical and medical device companies, with $2,447 received in 2024. These payments were reported across 705 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($14,546).
As a Medicare-enrolled provider, Oki has provided services to 2,060 Medicare beneficiaries, totaling 3,980 services with total Medicare billing of $298,321. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Aiea, HI
- Active Since 05/18/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982657268
Products in Payments
- Enbrel (Biological) $2,412
- XELJANZ (Drug) $1,488
- RINVOQ (Biological) $1,150
- COSENTYX (Biological) $1,131
- TALTZ (Drug) $942.90
- BENLYSTA (Biological) $856.65
- ACTHAR (Biological) $771.06
- KRYSTEXXA (Biological) $736.10
- LUPKYNIS (Drug) $674.82
- Cimzia (Drug) $474.09
- INFLECTRA (Biological) $433.74
- TAVNEOS (Drug) $432.58
- Rituxan (Biological) $391.77
- EVENITY (Biological) $363.87
- SKYRIZI (Biological) $196.27
- SAPHNELO (Biological) $171.96
- Rinvoq (Biological) $165.52
- Tymlos (Biological) $149.83
- FORTEO (Drug) $116.42
- Actemra (Biological) $114.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761
Dr. Michael Mihara, M.d, M.D
Internal Medicine — Payments: $13,527
Internal Medicine $13,527